Genetic Testing for Vascular Ehlers-Danlos Syndrome (vEDS)March 29, 2019
This report evaluates the clinical utility of genetic testing for vascular Ehlers-Danlos syndrome (vEDS) in 3 patient populations:
- Patients with vascular or digestive complications associated with vEDS.
- Patients who have a first-degree relative with a molecularly confirmed diagnosis of vEDS.
- Women with a personal or family history of vascular, digestive, or obstetric complications associated with vEDS for the purpose of family planning and/or pregnancy management.
If you have a Hayes login, click here to view the full report on the Knowledge Center.